Antidepressant medication use in patients undergoing revision arthroplasty; a nationwide longitudinal study
Approval date: December 2024
Starting date: May 8th 2025
MGJ Gademan, R Mahdad, RGHH Nelissen, M Yepes Calderon, J Vargas Centeno, BFP Broekman
Research proposal abstract
The number of arthroplasty surgeries is increasing rapidly. This procedure can sometimes lead to complications such as infections, aseptic loosening or periprosthetic fracture. These complications frequently result in the need of a revision surgery. Although the effect of revision arthroplasty in hospitalization time, patient mobility, and health care costs have been studied extensively, little is known about the effect of these medical complications on patient’s mental health. In this nationwide study, we will investigate whether patients undergoing revision arthroplasty of total hip or knee arthroplasty have an increased risk of developing mental health problems for which they are dispensed antidepressant medication. To answer the research question, we will use the data from the Dutch Arthroplasty Registry (LROI) and Dutch Foundation for Pharmaceutical Statistics (SFK) of patients who underwent an arthroplasty between 2013 and 2022 and assess antidepressant medication use in the first year after revision surgery. The findings of this study will give us a better understanding of the mental health impacts of revision arthroplasty and the magnitude of the problem.